Overview

Inflammatory Response to Anti Inflammatory Therapy in Children With Sleep Disordered Breathing

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will assess in a double blind placebo controlled fashion the effects of a 12 week course of oral montelukast/placebo on polysomnographic and radiological findings and will characterize the systemic (serum,urine) and local (upper airway collected biological samples) inflammatory response in children (2-10 years of age) with sleep disordered breathing, fittingthe inclusion and exclusion criteria.
Phase:
Phase 4
Details
Lead Sponsor:
Soroka University Medical Center
Treatments:
Anti-Inflammatory Agents
Montelukast